Filter
Period
Filter by
recent search
Showing: 1 – 05 of 124 Regulated Information
–
17 April 2024
17 April 2024
Ipsen publishes its 2023 Universal Registration Document
Ipsen publishes its 2023 Universal Registration Document
–
08 April 2024
08 April 2024
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
–
02 April 2024
02 April 2024
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
PARIS, FRANCE; SAN FRANCISCO, U.S., 02 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) and Sutro Biopharma (NASDAQ: STRO, “Sutro”, “the Company”) today announced an exclusive global licensing agreement for STRO-003. STRO-003, an antibody-drug conjugate (ADC) in the final stages…
–
07 March 2024
07 March 2024
Monthly information relative to the total number of voting rights and shares composing the share capital
Edited-Monthly information relative to the total number of voting rights and shares composing the share capital
–
15 February 2024
15 February 2024
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
Ipsen S.A. – 2023 Consolidated Financial Statements